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Objectives This study is a prospective validation of 6 mm2 as a minimum lumen area (MLA) cutoff value for revasculariza-
tion of left main coronary artery (LMCA) lesions.
Background Lesions involving the LMCA are prognostically relevant. Angiography has important limitations in the evaluation
of LMCA lesions with intermediate severity. An MLA of 6 mm2 assessed by intravascular ultrasound has been
proposed as a cutoff value to determine lesion severity, but there are no large studies evaluating the prospective
application and safety of this approach.
Methods We have designed a multicenter, prospective study. Consecutive patients with intermediate lesions in un-
protected LMCA were evaluated with intravascular ultrasound. An MLA 6 mm2 was used as criterion for
revascularization.
Results A total of 354 patients were included in 22 centers. LMCA revascularization was performed in 90.5% (152 of 168) of
patients with an MLA 6 mm2 and was deferred in 96% (179 of 186) of patients with an MLA of 6 mm2 or more. A
large scatter was observed between both groups regarding angiographic parameters. In a 2-year follow-up period,
cardiac death-free survival was 97.7% in the deferred group versus 94.5% in the revascularized group (p  0.5), and
event-free survival was 87.3% versus 80.6%, respectively (p  0.3). In the 2-year period, only 8 (4.4%) patients in the
deferred group required subsequent LMCA revascularization, none with an infarction.
Conclusions Angiographic measurements are not reliable in the assessment of intermediate LMCA lesions. An MLA of 6
mm2 or more is a safe value for deferring revascularization of the LMCA, given the application of the clinical and
angiographic inclusion criteria used in this study. (J Am Coll Cardiol 2011;58:351–8) © 2011 by the American
College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.02.064The limitations of angiographic assessment of left main
coronary artery (LMCA) lesion severity are well established
(1–3). Several studies have been published showing value of
intravascular ultrasound (IVUS) in the assessment of inter-
mediate LMCA lesions (4–11). A number of publications
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Nationwide IVUS Study for Left Main Lesions July 19, 2011:351–8There is currently no agree-
ment on what MLA value should
be used to determine whether to
treat an intermediate lesion. The
most frequently recommended
MLA value is 6 mm2; however,
there are no large prospective
validations of this cutoff value.
The 6-mm2 value was obtained
from Murray’s law (considering
an MLA of 4 mm2 as the isch-
emic threshold of the branches)
(12–14) and has been supported by
a study that used IVUS and pres-
sure wire flow fractional reserve
(FFR) (15). We previously pub-
lished the results of a prospective
application of a 6-mm2 MLA cut-
off value in 79 cases (10). This is
the first prospective and multi-
center study that assessed the usefulness of an IVUS-related
criterion to determine whether to revascularize intermediate
LMCA lesions.
Methods
The IVUS work team (from the Spanish Working Group of
Interventional Cardiology) designed a prospective and mul-
ticenter study involving patients with moderate LMCA
lesions by angiogram. We sought to assess the safety of a
6-mm2 MLA as a cutoff value to decide whether LMCA
esions need to be revascularized or if the procedure can be
eferred.
atients. Throughout 2007, in 22 Spanish institutions, all
onsecutive patients undergoing an angiogram for suspected
r confirmed coronary artery disease showing uncompli-
ated (no ulceration, dissection, or thrombus) intermediate
25% to 60% visual stenosis) unprotected LMCA lesions
ere included. Patients receiving primary percutaneous
oronary intervention (PCI) also were included, provided
he LMCA lesion was not the culprit. Exclusion criteria
ere: 1) cardiogenic shock; 2) left ventricular ejection
raction of 30%; 3) significant valvulopathy; and 4) any
oncomitant disease that could impair short-term survival.
All centers were strongly encouraged to adhere to the
rotocol-specified decision criteria for lesion treatment:
esions with an MLA of 6 mm2 or more were to remain
ntreated, whereas lesions with an MLA 6 mm2 were to
undergo revascularization (per operator choice, either coro-
nary artery bypass graft or PCI).
Imaging protocol and analysis. IVUS examination was
performed using the operator-preferred system. Ultrasound
images were recorded starting at a point distal to the
bifurcation of the left anterior descending and left circum-
flex arteries, and the entire LMCA was imaged to the
Abbreviations
and Acronyms
FFR  flow fractional
reserve
HBP  high blood pressure
IVUS  intravascular
ultrasound
LMCA  left main coronary
artery
LVEF  left ventricular
ejection fraction
MI  myocardial infarction
MLA  minimum lumen
area
MLD  minimum lumen
diameter
PCI  percutaneous
coronary interventionaorto-ostial junction with the catheter disengaged, allowingvisualization of the ostium. Motorized pull-backs were
performed at a speed of 0.5 mm/s after the administration of
intracoronary nitroglycerin.
The clinical decision of whether to treat was based on
online IVUS analysis. The studies were recorded in CD/
DVD and were sent to a core laboratory for analysis
(ICICOR, Hospital Clı´nico Universitario, Valladolid,
Spain). The quantitative coronary angiography and IVUS
analysis were performed by validated and automated edge-
detection software (Medis QCA CMS 6.0/XA 7.2 and
Medis QCU 1.0 [Medis Medical Imaging Systems Inc.,
Leiden, the Netherlands] and VIAS-Volcano Image Anal-
ysis Software [Volcano Inc., Rancho Cordova, California]).
Clinical follow-up. Two- and 5-year follow-ups were
planned. Follow-up information was collected by reviewing
clinical reports and by telephone interview in all cases. The
indication for repeated catheterization was driven clinically
and was decided by the clinical cardiologists.
Statistical analysis. Continuous variables were expressed
as mean  SD and were compared by unpaired Student t
tests. Categorical variables were expressed as percentages
and were compared by chi-square statistics or the Fisher
exact test, as indicated. A correlation test was used to
evaluate the degree of association between angiographic and
ultrasonographic measures. Kaplan-Meier analysis was used
to obtain an event-free survival rate, and log-rank tests were
applied to evaluate differences between groups. The level of
significance for hypothesis testing was p  0.05. SPSS
Statistics software version 15.0 (SPSS, Inc., Chicago, Illi-
nois) was used.
Results
During the study period, 358 patients underwent an IVUS
examination of intermediate LMCA lesions. Four patients
were excluded from the study because of inadequate quan-
titative IVUS assessment. The analysis comprised 354
patients (Fig. 1). Of the 186 patients with an MLA of 6
mm2 or more, 179 (96.2%) did not receive any revascular-
ization procedure of the LMCA (deferred group). Of the
168 patients with an MLA of 6 mm2, 152 (90.5%)
nderwent LMCA revascularization (revascularized group).
There were no significant differences in clinical charac-
eristics between the deferred and revascularized groups
Table 1). However, there were significant differences in
aseline angiographic characteristics (Table 2). As shown in
igure 2, there was a wide overlap and scatter of angio-
raphic stenosis and MLD relative to the MLA 6-mm2
cutoff. We obtained correlation coefficients for angiographic
stenosis and MLA, r  0.18 (p  0.0015), and for
angiographic MLD and MLA, r  0.34 (p  0.0001).
Seventeen percent of patients showed quantitative stenosis
of 30%, which was comparable with that of other similar
studies (16). Nevertheless, 33% of patients in this subgroup
had an MLA of 6 mm2. On the other side, in 43% of
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July 19, 2011:351–8 Nationwide IVUS Study for Left Main Lesionspatients with angiographic stenosis over 50%, the MLA was
larger than 6 mm2.
There were expected differences regarding ultrasono-
graphic characteristics between the 2 groups (Table 3).
Figure 3 illustrates the MLA and plaque burden of the
lesions in both groups. In the deferred group, those with an
MLA 9 mm2 showed an angiographic stenosis of 35 
0%, whereas in those with an MLA of 6 to 9 mm2 showed
n angiographic stenosis of 37  8% (p  0.1).
A total of 351 patients (99%) completed 2-years follow
p. In the deferred group, survival free from cardiac death
o 2 years was 97.7%. A total of 12 deaths were reported,
Figure 1 Flow Chart of the Study
CABG  coronary artery bypass graft; IVUS  intravascular ultrasound; LM  left
main; MLA  minimum lumen area; PCI  percutaneous coronary intervention;
pts  patients.
Clinical Characteristics of Both GroupsTable 1 Clinical Characteristics of Both Gro
Deferred Group
(n  179)
Age, yrs 66.5 11.0
Female 24 (13.4)
Diabetes 64 (35.8)
HBP 113 (63.1)
Smoker 45 (25.1)
Hypercholesterolemia 118 (65.9)
LVEF, % 56.6 10.0
Previous MI 52 (29)
Previous PCI 53 (29.6)
Previous CABG 5 (2.8)
STEMI 21 (11.7)
Unstable angina 64 (35.8)
Stable angina 74 (41.3)
Silent ischemia 20 (11.5)
Values are mean  SD or n (%).
CABG  coronary artery bypass graft; HBP  high blood pressure; LVE
PCI  percutaneous coronary intervention; STEMI  ST-segment elevation mnoncardiac (3 cancer, 2 infectious diseases, 1 bleeding,
nd 2 accidents) and 4 cardiac deaths. Among the latter
were patients older than 75 years with left ventricular
ysfunction and high clinical risk predictors. The MLA
as 8 mm2 in 3 of these patients and was 7 mm2 in the
emaining patient.
LMCA revascularization-free survival to 2 years in the
eferred group was 96.5%. LMCA revascularization was
equired in 8 patients: in 7 because of stable angina and in
after unstable angina. Angiographic progression was
bserved in 4 cases; however, the stenosis was 75% in
nly 1 case. Revascularization therapy was PCI in 6
atients (75%) and surgical in the other 2 patients (25%).
urvival free from cardiac death, MI, and LMCA revas-
ularization to 2 years in the deferred group was 94.2%,
hereas survival free from cardiac death, MI, and any
evascularization was 87.3%. Table 4 compares the clin-
cal characteristics of 8 deferred group patients who
eeded subsequent revascularization with those of the
71 patients who did not.
Figures 4 and 5 show comparative clinical outcomes from
oth the deferred and revascularized groups. Cardiac death-
ree survival was 97.7% in the deferred group versus 94.5%
n the revascularized group (p  0.5), and survival free from
ardiac death, MI, and any revascularization was 87.3%
ersus 80.6%, respectively (p  0.3).
Of the 168 patients with a baseline MLA6 mm2, there
ere 16 patients who did not undergo revascularization
ecause of operator or patient preferences, or both. The
LA was 5 to 6 mm2, and ejection fraction was preserved
in all but 2 cases. The lesions frequently were complex for
PCI (75% bifurcations and 37.5% heavily calcified), and 6
patients (37.5%) had problems for long-term dual antiplate-
let therapy. In addition, the estimated surgical risk was high
in 31% of patients (43.7% were older than age 75 years and
50% had lung or renal comorbidities), and 2 declined to
Revascularized Group
(n  152) p Value
65.2 11.0 0.30
33 (21.7) 0.06
57 (37.5) 0.80
91 (59.8) 0.60
44 (28.9) 0.50
101 (66.4) 0.90
58.1 10.0 0.07
42 (27.6) 0.70
41 (26.9) 0.70
8 (5.3) 0.30
13 (8.6) 0.40
52 (34.2) 0.80
60 (39.5) 0.80
17 (11.2) 0.90upsF  left ventricular ejection fraction; MI  myocardial infarction;
yocardial infarction.
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Nationwide IVUS Study for Left Main Lesions July 19, 2011:351–8undergo surgical revascularization. During follow-up, there
were 2 cardiac deaths, 3 patients had an MI, and 4 patients
underwent LMCA revascularization (2 PCI and 2 coronary
artery bypass graft). In this group of 16 patients, cardiac
death-free survival to 2 years was 86% (97.7% in the
deferred group; p 0.04), and survival free of cardiac death,
MI, and revascularization was 62.5% (87.3% in the deferred
group; p  0.02).
Discussion
This is the first multicenter, prospective study that assessed
the safety of an invasive tool to assist in the decision making
Angiographic Characteristics of Both GroupsTable 2 Angiographic Characteristics of Bot
Deferred Group
(n  179)
Visual stenosis, % 37.2 8.0
QCA stenosis, % 36.2 9.0
MLD, mm 2.5 0.6
RLD, mm 3.9 0.8
Ostial 75 (41.8)
Mid shaft 42 (23.4)
Bifurcation 62 (34.6)
Diffuse 25 (13.9)
Calcification 32 (17.8)
Isolated LMCA disease 35 (19.5)
Multivessel disease 68 (38)
No. of significant lesions* 1.53 1.00
Complete revascularization 116 (64.8)
Values are mean  SD or n (%). *Lesions in other segments of the co
LMCA left main coronary artery; MLDminimum lumen diameter
Figure 2 Individual Data Comparison Graphs
(A) Individual data comparison graph for angiographic left main coronary artery ste
parison graph for angiographic left main coronary artery minimum lumen diameter
group; MLD  minimum lumen diameter; QCA  quantitative coronary angiographregarding when to intervene in intermediate LMCA le-
sions. Our study supports the assertion that the IVUS-
derived cutoff value of 6 mm2 of MLA is safe in the context
f the inclusion and exclusion criteria of the current study.
Our study also corroborates the crucial limitations of
ngiography, already revealed in previous studies, when
rying to discriminate lesions with significant luminal nar-
owing. Moreover, the diffuse nature of the disease and the
hort length of the LMCA makes stenosis a less reliable
arameter in this location compared with other locations in
he coronary tree. The reference segments frequently are
iseased (as is evident by IVUS), and angiographic stenosis
ups
Revascularized Group
(n  152) p Value
47.4 10.0 0.001
40.4 10.0 0.002
2.3 0.7 0.005
3.6 0.8 0.008
33 (21.7) 0.002
44 (28.9) 0.30
75 (49.3) 0.01
47 (30.9) 0.001
47 (30.9) 0.008
18 (11.8) 0.07
74 (48.7) 0.06
1.90 1.00 0.0009
116 (76.3) 0.03
tree (no LMCA included).
quantitative coronary angiography; RLD reference lumen diameter.
in both intravascular ultrasound (IVUS)-derived groups. (B) Individual data com-
h IVUS-derived groups. Circles  deferred group; squares  revascularizedh Gronosis
in bot
y.
diamet
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July 19, 2011:351–8 Nationwide IVUS Study for Left Main Lesionsunderestimates the real lesion severity. This explains why
IVUS revealed significant luminal compromise even in
lesions with mild stenosis. Thus, in this study, we allowed
broad angiographic limits to be able to accommodate most
cases in which the operator believed that IVUS could
potentially help assess lesion severity. Obviously, lesions of
25% in several projections that caused no doubts regarding
Ultrasonographic Characteristics of Both GroupTable 3 Ultrasonographic Characteristics of
Deferred Grou
(n  179)
Lesion site
MLA, mm2 9.3 3.0
Maximum LD, mm 4.2 0.7
Minimum LD, mm 2.8 0.6
EEM area, mm2 20.2 5.5
Remodeling index 1.1 0.2
Plaque burden, % 52.6 12.0
Plaque burden 50% 109 (60.8)
Calcified 107 (59.7)
Circumference of CA, ° 80 77
Reference site
LA, mm2 14.9 5.0
EEM, mm2 22.8 6.6
Plaque burden, % 37.2 12.0
Values are mean  SD or n (%).
EEM  external elastic membrane; LA  lumen area; LD  lumen
Figure 3 Minimum Lumen Area and Plaque Burden Distribution
Minimum lumen area (MLA) and plaque burden distribution in (A, B) deferred grouseverity were not included in the current study. The same
rationale was applied for the inclusion of lesions in the
borderline range of 50% to 60% stenosis.
Abizaid et al. (8) verified the value of the IVUS-derived
MLD as an independent predictor of clinical events at 1
year in untreated LMCA lesions. The same research group
has published the results at 5 years demonstrating plaque
Groups
Revascularized Group
(n  152) p Value
4.8 0.8 0.001
3.1 0.7 0.001
2.2 0.3 0.001
16.1 5.0 0.001
1.2 0.3 0.001
67.5 11.0 0.001
149 (98) 0.001
108 (71) 0.07
91 76 0.08
11 4.0 0.001
19.5 5.0 0.001
43.5 16 0.001
er; MLA  minimum lumen area.
th Groups
(C, D) revascularized group.sBoth
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Nationwide IVUS Study for Left Main Lesions July 19, 2011:351–8burden to be the only independent predictor of cardiac
events (11).
The Mayo Clinic group reported a series of 214 patients
recruited in an 8-year period in which the cutoff value for
MLA was 7.5 mm2 (9). This value was derived from a
cohort of 121 patients with angiographically normal or
minimally diseased LMCA. The decision regarding
whether to revascularize was made following this criterion
in 86% of patients, and the clinical outcomes at a mean
follow-up of 3 years were similar in the patients with and
without revascularization.
Several studies also have been published that used
pressure wire to determine FFR, a more physiologically
relevant assessment tool. One of these studies compared
FFR with IVUS in a series of 55 patients. A close
correlation was found between FFR 0.75 and MLA
5.9 mm2 (15). Hamilos et al. (16) recruited 213
atients over 8 years from a single institution. Surgical
evascularization was indicated whenever FFR was 0.8.
his study pointed out the safety of this approach and the
oor correlation between FFR and angiography. Taken
Clinical, Angiographic, and Ultrasonographic Chin Patients With and Without Left Main CoronarRev scularization at Follow- p in the Deferred G
Table 4
Clinic l, Angi graphic, and Ultrason
in Patients With and Without Left M
Revascularization at Follow-Up in th
No Revasculariza
(n  171)
Clinical
Age, yrs 66.7 11.0
Female 22 (12.8)
Diabetes 61 (35.6)
HBP 108 (63.1)
Smoker 44 (25.7)
Hypercholesterolemia 113 (66)
LVEF % 56.3 10.0
STEMI 19 (11.1)
Stable angina 70 (40.9)
PCI other vessels 96 (56.1)
Angiography
Stenosis, % 36.3 8.0
MLD, mm 2.5 0.6
Ostial 73 (42.6)
Mid shaft 39 (22.8)
Bifurcation 59 (34.6)
Diffuse 24 (14)
Calcification 30 (17.5)
IVUS
MLD, mm 2.9 0.5
MLA, mm2 9.4 3.0
MLA 6–7 mm2 35 (20.4)
MLA 7–8 mm2 29 (16.9)
MLA 8–9 mm2 32 (18.7)
MLA 9 mm2 75 (43.8)
Plaque burden, % 52.2 13.0
Plaque burden 50% 105 (61.4)
Values are mean  SD or n (%).
IVUS  intravascular ultrasound; other abbreviations as in Tables 1ogether, the Mayo Clinic and Hamilos et al. (9,16) sACE incidence at 2 years in the nonrevascularized
roup are quite similar to that found in our study.
IVUS and FFR each have benefits and drawbacks as
ssessment tools. The main limitations of IVUS reside in
he potential lack of coaxiality and subsequent lumen
istortion, as well as in the negative impact of irregular
alcifications. Regarding FFR, the frequent concomitant
resence of lesions in the descending anterior coronary
rtery, circumflex, or both interferes with a proper
valuation of the LMCA lesion. One advantage of IVUS
ver pressure wire is that this tool can help both in the
iagnosis and the treatment of lesions. A potential
urvival impact derived from the use of IVUS already has
een proven (17).
tudy limitations. The main limitation of this study is
hat it was not randomized. Therefore, the value of the
omparison between deferred and revascularized groups
s limited by population differences between both strate-
ies. Only a randomized trial can validate the value of
evascularization according to pre-defined MLA cutoff
oints. However, considering the large body of evidence
eristicsryphic Characteristics
Coronary Artery
ferred Group
Revascularization
(n  8) p Value
62 11.0 0.20
2 (25) 0.60
3 (37.5) 0.80
5 (62.5) 0.70
1 (12.5) 0.70
5 (62.5) 0.80
52.2 14.0 0.30
2 (25) 0.60
4 (50) 0.90
4 (50) 0.90
40.2 10.0 0.20
2.6 0.5 0.60
2 (25) 0.50
3 (37.5) 0.60
3 (37.5) 0.80
1 (12.5) 0.70
2 (25) 0.90
2.5 0.7 0.07
8.4 2.1 0.40
2 (25) 0.90
2 (25) 0.90
1 (12.5) 0.90
3 (37.5) 0.90
59.1 14.0 0.10
6 (75) 0.70
3.aracty Artroupogra
ain
e De
tionuggesting the clinical value of this cutoff criterion, we
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July 19, 2011:351–8 Nationwide IVUS Study for Left Main Lesionsselected a pragmatic strategy in which this single criterion
was selected to guide revascularization decisions. This
was considered to be the only viable study (ethical issues
were raised in the initial discussions on study design).
Another limitation is the lack of complete adherence to
protocol, although protocol adherence was high and greater
than in previous similar studies. A third limitation is the
selection of patients based on the subjective operator criteria
for intermediate lesions. However, this potential bias is
reduced by the multicenter design. Finally, the follow-up
period is only 2 years. However, the goal of this study
resides in studying the ischemic potential of intermediate
lesions, and not in assessing the progression of atheroscle-
rotic lesions.
Conclusions
Angiographic measurements are not reliable in the as-
sessment of intermediate LMCA lesions. Ultrasono-
graphic evaluation of intermediate LMCA lesions allows
precise assessment of lesion severity, as well as lesion
characteristics useful in cases where PCI is used to
revascularize. An MLA of 6 mm2 or more seems to be a
safe value for deferring revascularization of the LMCA,
provided the application of the clinical and angiographic
criteria used in this study.
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